Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003

Clinical Microbiology and Infection

Volumn 13, Issue 8, 2007, Pages 824-826

  Tamm, Eda ^a   Naaber, P ^b   Maimets, M ^a   Oona, M ^a   Koljalg S ^b   Lutsar, I ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY CLINICS   (Estonia)

Author keywords

Antibiotic susceptibility; Estonia; Nasopharyngeal carriage; Penicillin non susceptible; Serotypes; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; TETRACYCLINE;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CHILD HEALTH; CONTROLLED STUDY; CROSS REACTION; DAY CARE; ESTONIA; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NASOPHARYNX; NORMAL HUMAN; NOSE SMEAR; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; WINTER;

STREPTOCOCCUS PNEUMONIAE;

EID: 34447273328     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01743.x     Document Type: Article

References (10)

1. Martynova AV, Turcutyuicov VB. Macrolide resistance in Streptococcus pneumoniae strains collected in the Far East of Russia from 2000 to 2002. J Clin Microbiol 2000; 41: 4906.
2. Stratchounski LS, Kretchikova OI, Kozlov RS et.al. Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: Results of a multicenter study in Russia. Pediatr Infect Dis J 2000; 19: 196-200.
3. Naaber P, Tamm E, Putsepp A, Koljalg S, Maimets M. Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clin Microbiol Infect 2000; 6: 675-677.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 12th informational supplement. Wayne, PA: NCCLS, 2002.
5. World Health Organisation. Anatomical therapeutical chemical (ACT) classification index including defined daily doses (DDDs) for plain substances. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1992.
6. Pihlajamaki M, Jalava J, Huovinen P, Kotilainen P. Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000. Antimicrob Agents Chemother 2003; 47: 1832-1855.
7. Goossens H, Ferech M, Van der Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-587.
8. Principi N, Marchisio P, Schito GC, Mannelli S. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J 1999; 18: 517-523.
9. Syrjanen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis 2001; 184: 451-459.
10. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5: 83-93.